Literature DB >> 8373364

Ascorbic acid accumulation and transport in human fibroblasts.

R W Welch1, P Bergsten, J D Butler, M Levine.   

Abstract

As the initial step in the use of fibroblasts as a model system for 'in situ kinetics', ascorbic acid (vitamin C) accumulation in normal human fibroblasts was investigated for the first time. Ascorbic acid was transported into fibroblasts and accumulated against a concentration gradient up to 20-fold, as measured by h.p.l.c. with coulometric electrochemical detection. Ascorbic acid accumulation was mediated by two concentration-dependent transport activities. The first was a high-affinity activity with an apparent Km of 6 microM and an apparent Vmax. of 203 microM/h, and the second was a low-affinity activity with an apparent Km of 5 mM and an apparent Vmax. of 1.8 mM/h. Both activities were inhibited by metabolic inhibitors and inhibitors of ascorbic acid transport in human neutrophils. The low-affinity transporter could not be accounted for by diffusion. Although the high-affinity transport activity was comparable with that described for human neutrophils, the low-affinity transporter was different. These data provide the first evidence that two-component ascorbic acid transport may be a generalized mechanism for accumulation of this vitamin in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373364      PMCID: PMC1134483          DOI: 10.1042/bj2940505

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex.

Authors:  J Risteli; K Tryggvason; K I Kivirikko
Journal:  Eur J Biochem       Date:  1977-03-01

Review 2.  Insulin-sensitive glucose transport.

Authors:  T Kono
Journal:  Vitam Horm       Date:  1988       Impact factor: 3.421

3.  Affinity column purification of protocollagen proline hydroxylase from chick embryos and further characterization of the enzyme.

Authors:  R A Berg; D J Prockop
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

Review 4.  New concepts in the biology and biochemistry of ascorbic acid.

Authors:  M Levine
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

5.  Characterization of the ascorbic acid transport by 3T6 fibroblasts.

Authors:  H Padh; J J Aleo
Journal:  Biochim Biophys Acta       Date:  1987-07-23

6.  Characterization of ascorbic acid transport by adrenomedullary chromaffin cells. Evidence for Na+-dependent co-transport.

Authors:  E J Diliberto; G D Heckman; A J Daniels
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

7.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

8.  Inhibition of ascorbic acid transport in human neutrophils by glucose.

Authors:  P Washko; M Levine
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Ascorbic acid specifically enhances dopamine beta-monooxygenase activity in resting and stimulated chromaffin cells.

Authors:  M Levine
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

10.  Ascorbic acid transport and accumulation in human neutrophils.

Authors:  P Washko; D Rotrosen; M Levine
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

View more
  18 in total

1.  Moderately controlled transport of ascorbate into aortic endothelial cells against slowdown of the cell cycle, decreasing of the concentration or increasing of coexistent glucose as compared with dehydroascorbate.

Authors:  Y Saitoh; N Nagao; R O'Uchida; T Yamane; K Kageyama; N Muto; N Miwa
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

Review 2.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

3.  Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion.

Authors:  J F Graumlich; T M Ludden; C Conry-Cantilena; L R Cantilena; Y Wang; M Levine
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

4.  Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

Authors:  M Levine; C Conry-Cantilena; Y Wang; R W Welch; P W Washko; K R Dhariwal; J B Park; A Lazarev; J F Graumlich; J King; L R Cantilena
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 5.  Genetic Variation in Human Vitamin C Transporter Genes in Common Complex Diseases.

Authors:  Mandana Amir Shaghaghi; Olena Kloss; Peter Eck
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

6.  Efflux of hepatic ascorbate: a potential contributor to the maintenance of plasma vitamin C.

Authors:  J M Upston; A Karjalainen; F L Bygrave; R Stocker
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

7.  Effect of temperature, pH and heme ligands on the reduction of Cygb(Fe(3+)) by ascorbate.

Authors:  Jianjing Tong; Joseph R Zweier; Rachael L Huskey; Raed S Ismail; Craig Hemann; Jay L Zweier; Xiaoping Liu
Journal:  Arch Biochem Biophys       Date:  2014-04-26       Impact factor: 4.013

Review 8.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: identification as glutaredoxin.

Authors:  J B Park; M Levine
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.